Dr. Reddy's Launches World's First Aranesp Biosimilar In India, Vows To Bring Out More
This article was originally published in The Pink Sheet Daily
Executive Summary
The Indian drug maker has officially kept its biosimilar pipeline secret but has indicated that it includes a pegylated molecule in late-stage clinical trials, two other products scheduled to enter clinical trials, and several others in early stage development.